In adults with active dermatomyositis, IV immune globulin improved treatment response at 16 wk vs. placebo.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 36745896.
- Also identified by DOI 10.7326/J22-0111.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Aggarwal R, Charles-Schoeman C, Schessl J, et al. <b>Trial of intravenous immune globulin in dermatomyositis.</b> N Engl J Med. 2022;387:1264-78. 36198179.
Medical subject headings
- Dermatomyositis
- Immunoglobulins, Intravenous